October 25 2017
By Mary Henningfield, PhD, Director of Scientific Training and Analysis
Free to Breathe (now merged with the Lung Most cancers Analysis Basis) is proud to be a member of the World Lung Most cancers Coalition (GLCC). Not solely is lung most cancers the primary most cancers killer in the US, however worldwide as properly.
The GLCC not too long ago held a gathering in Tokyo, Japan, previous to the 18th World Convention on Lung Most cancers (WCLC). The GLCC is the worldwide “voice” of sufferers with lung most cancers. Fashioned in 2001, the GLCC consists of 37 affected person organizations from 26 nations worldwide.
A key initiative of GLCC is the creation of the e-atlas. This useful resource offers information on lung most cancers incidence, mortality, survival and nationwide coverage for nations worldwide. GLCC additionally performs analysis, together with a bibliometric research that checked out revealed research to offer insights into analysis outputs. Lung most cancers analysis represented solely 5.6% of general most cancers analysis in 2013, a 1.2% improve since 2004. Of the 24 nations included within the research, the US accounted for probably the most revealed analysis in the course of the 10-year interval evaluated. Roughly 20% of the articles targeted on genetics and fewer than 1% targeted on high quality of life. Analysis on palliative care was additionally low.1 This work highlights the necessity for better efforts to prioritize lung most cancers analysis. The Lung Most cancers Analysis Basis will proceed to fund revolutionary, high-reward analysis which may in any other case go uninvestigated. We fund each U.S. and worldwide researchers of all expertise ranges with the purpose of selling innovation amongst a broad vary of investigators.
The WCLC in Yokohama, Japan, adopted the GLCC assembly of the member organizations. The WCLC is solely targeted on lung most cancers analysis. Many attendees had been excited to be taught that the Presidential Symposium of the Prime three Abstracts included necessary analysis into patient-reported outcomes in a scientific trial of an immunotherapy. The convention additionally had a particular observe for affected person advocacy, together with a joint session with the Worldwide Affiliation for the Examine of Lung Most cancers and GLCC to debate present points in lung most cancers advocacy. Displays included matters reminiscent of using GLCC information, measuring worth in healthcare, and accessing new lung most cancers therapies in Latin America.
1. Aggarwal A, Lewison G, Idir S, et al. The state of lung most cancers analysis: A worldwide evaluation. J Thorac Oncol. 2016;11(7):1040-1050.